{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:23:06Z","timestamp":1788340986985,"version":"build-2803163510"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Study Design:<\/jats:title>\n                    <jats:p>Retrospective matched-cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To evaluate the clinical efficacy, safety, and economic impact of a novel cellular bone allograft (PrimaGen Advanced Allograft; CBA-P) used in combination with recombinant human bone morphogenetic protein-2 (rhBMP-2) for short-segment lumbar interbody fusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary of Background Data:<\/jats:title>\n                    <jats:p>Osteobiologic grafts are increasingly used to optimize lumbar interbody fusion outcomes. Recombinant human bone morphogenetic protein-2 (rhBMP-2) improves fusion rates but is costly and associated with complications. Cellular bone allografts (CBAs) aim to enhance fusion by providing a bony scaffold, growth factors, and viable cells, but their clinical and economic benefit remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We retrospectively assessed 100 adults who underwent 1- or 2-level posterior or transforaminal lumbar interbody fusion between 2017 and 2023. Fifty patients received CBA-P with rhBMP-2 (experimental cohort), and 50 matched controls received rhBMP-2 with standard-of-care demineralized bone matrix and\/or allograft bone powder. Matching was based on age decade, sex, and fusion level. The primary outcome was interbody fusion at 12 and 24 months, assessed using a validated radiograph measurement platform. Secondary outcomes included revision surgery, complications, pain scores, and per-case osteobiologic cost.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Fusion rates were similar between cohorts at 12 months (95.7% vs. 89.1%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.27) and 24 months (100% vs. 89.5%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.49), with comparable revision and complication rates. Estimated blood loss (364.4 vs. 232.9\u00a0mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.001) and 6-month pain scores (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.03) were higher in the experimental cohort. CBA-P use significantly increased per-case osteobiologic cost ($9478 vs. $5252,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt;0.0001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Use of CBA-P with rhBMP-2 did not improve fusion rates, reduce complications, or enhance pain outcomes, yet markedly increased surgical cost. These findings do not clearly support the routine use of CBA-P alongside rhBMP-2 in short-segment lumbar interbody fusion and highlight the need for well-designed prospective studies to define its standalone clinical value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence:<\/jats:title>\n                    <jats:p>Level III.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bsd.0000000000002154","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:01:31Z","timestamp":1788339691000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Role of a Novel, Fresh-Frozen Cellular Bone Allograft in Lumbar Interbody Spinal Fusion"],"prefix":"10.1097","author":[{"given":"Charles P.","family":"Nolte","sequence":"first","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Singh","sequence":"additional","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Ishmael","sequence":"additional","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Wipf","sequence":"additional","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdian","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriy","family":"Noshchenko","sequence":"additional","affiliation":[{"name":"School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Anschutz Medical Campus, University of Colorado, Aurora, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"R1-20260902","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3171\/spi.2005.2.6.0670","article-title":"Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 7: intractable low-back pain without stenosis or spondylolisthesis","volume":"2","author":"Resnick","year":"2005","journal-title":"J Neurosurg Spine"},{"key":"R2-20260902","first-page":"2","article-title":"Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF\/ATP, LLIF and ALIF","volume":"1","author":"Mobbs","year":"2015","journal-title":"J Spine Surg"},{"key":"R3-20260902","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5435\/00124635-200803000-00004","article-title":"Posterior lumbar interbody fusion","volume":"16","author":"DiPaola","year":"2008","journal-title":"J Am Acad Orthop Surg"},{"key":"R4-20260902","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2106\/00004623-195335040-00024","article-title":"Posterolateral fusion of the lumbar and lumbosacral spine","volume":"35-A","author":"Watkins","year":"1953","journal-title":"J Bone Joint Surg Am"},{"key":"R5-20260902","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2009.7.FOCUS09121","article-title":"Minimally invasive spine technology and minimally invasive spine surgery: a historical review","volume":"27","author":"Oppenheimer","year":"2009","journal-title":"Neurosurg Focus"},{"key":"R6-20260902","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5435\/JAAOS-D-15-00756","article-title":"Transforaminal lumbar interbody fusion: traditional open versus minimally invasive techniques","volume":"26","author":"Lee","year":"2018","journal-title":"J Am Acad Orthop Surg"},{"key":"R7-20260902","first-page":"175","article-title":"Radiological and clinical outcomes of transforaminal vs posterior lumbar interbody fusions: a systematic review","volume":"34","author":"Vahedi","year":"2024","journal-title":"Turk Neurosurg"},{"key":"R8-20260902","doi-asserted-by":"crossref","first-page":"107061","DOI":"10.1016\/j.clineuro.2021.107061","article-title":"Outcomes of anterior vs posterior approach to single-level lumbar spinal fusion with interbody device: an analysis of the Nationwide Inpatient Sample","volume":"212","author":"De Stefano","year":"2022","journal-title":"Clin Neurol Neurosurg"},{"issue":"suppl 2","key":"R9-20260902","first-page":"S96","article-title":"Osteoinduction, osteoconduction and osseointegration","volume":"10","author":"Albrektsson","year":"2001","journal-title":"Eur Spine J"},{"key":"R10-20260902","doi-asserted-by":"crossref","first-page":"17365","DOI":"10.3390\/ijms242417365","article-title":"Osteobiologies for spinal fusion from biological mechanisms to clinical applications: a narrative review","volume":"24","author":"Keum","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R11-20260902","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1097\/BSD.0000000000001262","article-title":"A review of commercially available cellular-based allografts","volume":"35","author":"Pinter","year":"2022","journal-title":"Clin Spine Surg"},{"key":"R12-20260902","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.31616\/asj.2022.0435","article-title":"Lumbar interbody fusion and osteobiologics for lumbar fusion","volume":"16","author":"Kim","year":"2022","journal-title":"Asian Spine J"},{"key":"R13-20260902","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00007632-200107010-00018","article-title":"Natural history of posterior iliac crest bone graft donation for spinal surgery: a prospective analysis of morbidity","volume":"26","author":"Robertson","year":"2001","journal-title":"Spine (Phila Pa 1976)"},{"key":"R14-20260902","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3928\/01477447-20100225-08","article-title":"Acute and chronic complications of intracortical iliac crest bone grafting versus the traditional corticocancellous technique for spinal fusion surgery","volume":"33","author":"Lementowski","year":"2010","journal-title":"Orthopedics"},{"key":"R15-20260902","doi-asserted-by":"crossref","first-page":"E729","DOI":"10.1097\/BRS.0000000000003372","article-title":"Comparative clinical effectiveness and safety of bone morphogenetic protein versus autologous iliac crest bone graft in lumbar fusion: a meta-analysis and systematic review","volume":"45","author":"Liu","year":"2020","journal-title":"Spine (Phila Pa 1976)"},{"key":"R16-20260902","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.actbio.2023.08.045","article-title":"Osteogenic effects of covalently tethered rhBMP-2-2 and rhBMP-2-9 in an MMP-sensitive PEG hydrogel nanocomposite","volume":"170","author":"Schoonraad","year":"2023","journal-title":"Acta Biomater"},{"key":"R17-20260902","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.spinee.2023.07.017","article-title":"Fusion rate of Escherichia coli-derived recombinant human bone morphogenetic protein-2 compared with local bone autograft in posterior lumbar interbody fusion for degenerative lumbar disorders","volume":"23","author":"Park","year":"2023","journal-title":"Spine J"},{"key":"R18-20260902","doi-asserted-by":"crossref","first-page":"101765","DOI":"10.1016\/j.inat.2023.101765","article-title":"Comparison of fusion outcomes of bone morphogenetic protein-7 and bone autograft in posterolateral lumbar fusion: a systematic review","volume":"33","author":"Subagio","year":"2023","journal-title":"Interdiscip Neurosurg"},{"key":"R19-20260902","doi-asserted-by":"crossref","first-page":"86","DOI":"10.14444\/8394","article-title":"Experience with recombinant human bone morphogenetic protein-2 in posterior lumbar interbody fusion: a retrospective review of 1019 procedures","volume":"17","author":"Trang","year":"2023","journal-title":"Int J Spine Surg"},{"key":"R20-20260902","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.otsr.2019.04.023","article-title":"rhBMP-2-2 (recombinant human bone morphogenetic protein-2) in real-world spine surgery: a phase IV, national, multicentre, retrospective study collecting data from patient medical files in French spinal centres","volume":"105","author":"Vincentelli","year":"2019","journal-title":"Orthop Traumatol Surg Res"},{"key":"R21-20260902","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.spinee.2017.08.230","article-title":"Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2-2 versus autograft","volume":"18","author":"Khan","year":"2018","journal-title":"Spine J"},{"key":"R22-20260902","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1097\/01.brs.0000245863.52371.c2","article-title":"Increased swelling complications associated with off-label usage of rhBMP-2-2 in the anterior cervical spine","volume":"31","author":"Smucker","year":"2006","journal-title":"Spine"},{"key":"R23-20260902","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.spinee.2013.08.060","article-title":"Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery","volume":"14","author":"Tannoury","year":"2014","journal-title":"Spine J"},{"key":"R24-20260902","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1097\/BSD.0000000000000079","article-title":"Cost-utility analysis of 1- and 2-level dorsal lumbar fusions with and without recombinant human bone morphogenic protein-2 at 1-year follow-up","volume":"29","author":"Alvin","year":"2016","journal-title":"Clin Spine Surg"},{"key":"R25-20260902","first-page":"193","article-title":"The use of osteoconductive stem-cells allograft in lumbar interbody fusion procedures: an alternative to recombinant human bone morphogenetic protein","volume":"20","author":"Kerr","year":"2011","journal-title":"J Surg Orthop Adv"},{"key":"R26-20260902","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.spinee.2014.05.024","article-title":"Cellular bone matrices: viable stem cell-containing bone graft substitutes","volume":"14","author":"Skovrlj","year":"2014","journal-title":"Spine J"},{"key":"R27-20260902","doi-asserted-by":"crossref","first-page":"e1084","DOI":"10.1002\/jsp2.1084","article-title":"Comparing cellular bone matrices for posterolateral spinal fusion in a rat model","volume":"3","author":"Lin","year":"2020","journal-title":"JOR Spine"},{"key":"R28-20260902","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00586-016-4414-7","article-title":"A prospective clinical and radiographic 12-month outcome study of patients undergoing single-level anterior cervical discectomy and fusion for symptomatic cervical degenerative disc disease utilizing a novel viable allogeneic cancellous bone matrix (Trinity Evolution) with a comparison to historical controls","volume":"25","author":"Vanichkachorn","year":"2016","journal-title":"Eur Spine J"},{"key":"R29-20260902","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1186\/s12891-021-04584-z","article-title":"Lumbar spine fusion outcomes using a cellular bone allograft with lineage-committed bone-forming cells in 96 patients","volume":"22","author":"Elgafy","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"R30-20260902","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/BSD.0000000000001475","article-title":"Anterior cervical discectomy and fusions supplemented with cellular or noncellular allografts have similar radiographic fusion and clinical outcomes","volume":"36","author":"Zakko","year":"2023","journal-title":"Clin Spine Surg"},{"key":"R31-20260902","doi-asserted-by":"crossref","first-page":"372","DOI":"10.21037\/jss-23-142","article-title":"Efficacy of an allograft cellular bone matrix as an alternative to autograft in anterior cervical discectomy and fusion: radiological results and safety","volume":"10","author":"Goldman","year":"2024","journal-title":"J Spine Surg"},{"key":"R32-20260902","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s13018-021-02829-0","article-title":"A 24-month retrospective update: follow-up hospitalization charges and readmissions in US lumbar fusion surgeries using a cellular bone allograft (CBA) versus recombinant human bone morphogenetic protein-2 (rhBMP-2-2)","volume":"16","author":"Wetzell","year":"2021","journal-title":"J Orthop Surg Res"},{"key":"R33-20260902","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.3390\/ma14123290","article-title":"Commercial bone grafts claimed as an alternative to autografts: current trends for clinical applications in orthopaedics","volume":"14","author":"Govoni","year":"2021","journal-title":"Materials (Basel)"},{"key":"R36-20260902","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.spinee.2024.08.007","article-title":"Diagnosis of spine pseudoarthrosis based on the biomechanical properties of bone","volume":"24","author":"Hipp","year":"2024","journal-title":"Spine J"}],"container-title":["Clinical Spine Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BSD.0000000000002154","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:01:37Z","timestamp":1788339697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/BSD.0000000000002154"}},"subtitle":["A Retrospective, Matched-Cohort Study"],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":34,"URL":"https:\/\/doi.org\/10.1097\/bsd.0000000000002154","relation":{},"ISSN":["2380-0186","2380-0194"],"issn-type":[{"value":"2380-0186","type":"print"},{"value":"2380-0194","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"2025-11-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}